Saliva level of free 3-methoxy-4-hydroxyphenylglycol in psychiatric outpatients with anxiety.
As a measurement of the level of anxiety in psychiatric outpatients with anxiety, we determined the saliva level of free 3-methoxy-4-hydroxyphenyleglycol (MHPG) using gas chromatography- mass spectrometry and scored the levels of anxiety with the Hamilton Anxiety Scale (HAS) in patients, before and after drug treatment with alprazolam for 1 week. The saliva level of free-MHPG at first visit to hospital was significantly higher than that of control individuals and disease control individuals and was reduced by alprazolam treatment for 1 week. There was no correlation between MHPG level and the HAS score at the first hospital visit. The MHPG levels after treatment correlated with the HAS scores. The reduction of the anxiety level as scored by the HAS correlated with the reduction of MHPG level. These results indicate that the free saliva MHPG level may be a useful indicator for assessing not only the level of anxiety, but also the response to drug treatment for anxiety in these patients.
Yamada
S
S
Institute of Brain Diseases, Kurume University School of Medicine, Japan. S-yamada@kurume.ktarn.or.jp
Yajima
J
J
Harano
M
M
Miki
K
K
Nakamura
J
J
Tsuda
A
A
Shoji
H
H
Maeda
H
H
Tanaka
M
M
D000328:Adult; D000525:Alprazolam / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy / Q000378:metabolism* / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000378:metabolism*; D008875:Middle Aged; D010045:Outpatients; D011569:Psychiatric Status Rating Scales; D012463:Saliva / Q000378:metabolism*
D014151:Anti-Anxiety Agents; D008734:Methoxyhydroxyphenylglycol; D000525:Alprazolam